SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-051381
Filing Date
2006-08-04
Accepted
2006-08-04 09:59:18
Documents
6
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-15199_110q.htm 10-Q 1091314
2 EX-10 a06-15199_1ex10d1.htm EX-10.1 66277
3 EX-31 a06-15199_1ex31d1.htm EX-31.1 12125
4 EX-31 a06-15199_1ex31d2.htm EX-31.2 12490
5 EX-32 a06-15199_1ex32d1.htm EX-32.1 6656
6 EX-32 a06-15199_1ex32d2.htm EX-32.2 7380
  Complete submission text file 0001104659-06-051381.txt   1197626
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 061004071
SIC: 2834 Pharmaceutical Preparations